The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
NCT00259727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2009-09-30
Summary
The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.
Conditions
- Diabetes
- HIV Infections
- Insulin Resistance
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Grace Lee, MD · VA Medical Center, San Francisco
Eligibility
- Min Age
- 18 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities
NCT00152893 ·Status: COMPLETED ·Phase: PHASE2
-
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
NCT00021463 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Abnormalities in HIV-infected Persons
NCT01612858 ·Status: COMPLETED ·Phase: PHASE4
-
Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.
NCT05135039 ·Status: UNKNOWN ·Phase: NA
-
Impact of Metformin on Immuno-virologic Parameters in HIV
NCT04500678 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
NCT00656851 ·Status: COMPLETED ·Phase: NA
-
Metformin for HIV Inflammation
NCT02383563 ·Status: UNKNOWN ·Phase: PHASE2
-
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
NCT00067587 ·Status: COMPLETED
-
Lifestyle Modification and Metformin Use in the Treatment of HIV
NCT00399360 ·Status: COMPLETED ·Phase: NA
-
Exercise and Pioglitazone for HIV-Metabolic Syndromes
NCT00639457 ·Status: COMPLETED ·Phase: NA
-
Lactate Metabolism Study in HIV Infected Persons
NCT00202228 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Activation as a Cause of Insulin Resistance in Adults Living With HIV-1 on Effective Antiretroviral Therapy
NCT04028882 ·Status: TERMINATED
-
Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
NCT00119405 ·Status: COMPLETED
-
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
NCT00433628 ·Status: COMPLETED
-
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
NCT05208671 ·Status: RECRUITING ·Phase: NA
-
2-5 Intermittent Caloric Restriction in HIV
NCT03489109 ·Status: TERMINATED ·Phase: NA
-
Effects of Diet on Brain Processing
NCT02835820 ·Status: COMPLETED ·Phase: NA
-
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
NCT00575939 ·Status: COMPLETED
-
Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients
NCT06279819 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312 ·Status: ENROLLING_BY_INVITATION
-
Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution
NCT00025753 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
NCT00130286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay
NCT02026752 ·Status: COMPLETED
-
Antiplatelet Therapy in HIV
NCT02559414 ·Status: COMPLETED ·Phase: PHASE2